GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. Approved in 2023, Jesduvroq, (HIF-PHI), is ...

The approval was based on phase 3 data from the randomized, double-blind, placebo-controlled CAHtalyst adult study and CAHtalyst pediatric study.

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) ...

The approval was based on data from 2 randomized, double-blind, placebo-controlled trials, ARCADIA 1 and ARCADIA 2.

Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

Researchers evaluated the association between epidural steroid injection use and fracture incidence among older patients with radicular pain.

Health care workers with disabilities face significant challenges, such as employment discrimination, lack of accessibility, and ableism.